EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer

Hui Li, Weiguang Yuan, Jialin Liu, Yingjie Wang, Fang Fang, Yuanyuan Yu, Jianxun Hou, Mengru Jin, Siwei Li, Siyu Liu, Yajie Gong, Yijun Chu und 9 weitere

Nanoscale · 2026

DOI: 10.1039/d5nr04841a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2026. Verfasst von Hui Li und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Exosomes, Proto-Oncogene Proteins c-myc, Oligopeptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Natural Science Foundation of China, Harbin Medical University Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive cancer with a poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsExosomesProto-Oncogene Proteins c-mycOligopeptidesHumansAnimalsFemaleMiceCell Line, TumorApoptosisCell ProliferationMice, NudeXenograft Model Antitumor Assays

Substanzen

Proto-Oncogene Proteins c-mycOligopeptidesMYC protein, humanN-end cysteine peptide tumor-homing peptidearginyl-glycyl-aspartic acid

Autor:innen und Institutionen

  • Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin, China.
  • Institute of Cancer Prevention and Treatment, Heilongjiang Academy of Medical Sciences, Harbin, China.
  • Heilongjiang Clinical Research Center for Breast Cancer, Harbin Medical University Cancer Hospital, Harbin, China. zhangxianyu@ems.hrbmu.edu.cn.
  • Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.

Förderung

  • National Natural Science Foundation of China
  • Harbin Medical University Cancer Hospital

Zitieren

APA

Li, H., Yuan, W., Liu, J., Wang, Y., Fang, F., Yu, Y., Hou, J., Jin, M., Li, S., Liu, S., Gong, Y., Chu, Y., Zhang, X., Zhao, S., Hao, W., Qin, X., Fan, Q., Chen, X., Zhang, Y., …, & Zhang, X. (2026). iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer. Nanoscale. https://doi.org/10.1039/d5nr04841a

Vancouver

Li H, Yuan W, Liu J, Wang Y, Fang F, Yu Y, et al. iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer. Nanoscale. 2026. doi:10.1039/d5nr04841a

BibTeX
@article{Li2026,
  author = {Li, Hui and Yuan, Weiguang and Liu, Jialin and Wang, Yingjie and Fang, Fang and Yu, Yuanyuan and Hou, Jianxun and Jin, Mengru and Li, Siwei and Liu, Siyu and Gong, Yajie and Chu, Yijun and Zhang, Xingda and Zhao, Shilu and Hao, Wenhui and Qin, Xuquan and Fan, Qinchen and Chen, Xi and Zhang, Youxue and Pang, Da and Zhang, Xianyu},
  title = {iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer},
  journal = {Nanoscale},
  year = {2026},
  doi = {10.1039/d5nr04841a}
}
Kostenlos starten →